ERS 2023 Insights

 

ERS 2023 Insights
P

ERS 2023 Insights: Is Vaping an Effective (and Safe) Aid for Quitting Smoking? The Cochrane Review of Electronic Cigarettes for Smoking Cessation

By ERS 2023 Insights FEATURING Peter Hajek
By ERS 2023 Insights FEATURING Peter Hajek
558 views
September 20, 2023
Comments 1
Login to view comments. Click here to Login
Videos
22:58

ERS 2023 Insights: Sarcoidosis - When Is HRCT Not Enough and When Sh…

ERS 2023 Insights

A. Tarnoki

502 views
15:05

ERS 2023 Insights: Novel Immune Mechanisms of COPD Initiation and Pr…

ERS 2023 Insights

F. Polverino

565 views
22:24

ERS 2023 Insights: Pharmacological Treatment and Current Controversi…

ERS 2023 Insights

K. Kostikas

1.3K views
17:18

ERS 2023 Insights: Novel Methods of Symptom Monitoring and Managemen…

ERS 2023 Insights

K. Ilene Aronson

673 views
13:43

ERS 2023 Insights: Are Approved PAH Drugs Disease-Modifying?

ERS 2023 Insights

O. Sitbon

271 views
11:04

ERS 2023 Insights: Post Hoc Analyses of Senolytic Pilot Trials in Id…

ERS 2023 Insights

D. Kellogg

276 views
08:11

ERS 2023 Insights: A Long-Term Follow-Up Study of Sotatercept for Pu…

ERS 2023 Insights

I. Preston

279 views
12:01

ERS 2023 Insights: Different Thrombus Recanalization Strategies in P…

ERS 2023 Insights

D. Jimenez

306 views
13:29

ERS 2023 Insights: Obstructive Sleep Apnea and Pulmonary Embolism - …

ERS 2023 Insights

A. Ortega

581 views
07:13

ERS 2023 Insights: Blood Eosinophil Count Measured Before Starting I…

ERS 2023 Insights

A. Mathioudakis

458 views
18:39

ERS 2023 Insights: Is Vaping an Effective (and Safe) Aid for Quittin…

ERS 2023 Insights

P. Hajek

558 views
16:36

ERS 2023 Insights: Defining Disease Modification in PAH

ERS 2023 Insights

S. Sahay

463 views
12:50

ERS 2023 Insights: Management of Dyspnea in ILD

ERS 2023 Insights

Y. Khor

471 views
21:38

ERS 2023 Insights: Should β-Blockers Be Used in Patients With Chroni…

ERS 2023 Insights

A. Kaplan

857 views
12:58

ERS 2023 Insights: Evolution in GOLD - We Cannot "See" "C" Anymore a…

ERS 2023 Insights

A. Anzueto

1.4K views